Article
At Least Six Killed, Dozens Wounded in Lebanon as Israel Attacks Area Around Hospital in Tyre
The casualties among healthcare workers in Lebanon have continued to grow this weekend, with the IDF attacking the area around Hiram Hospital in the city of Tyre, causing “severe damage” to the hospital itself and wounding at least 13 paramedics in the district. At least six people were killed and dozens wounded in various strikes […]
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Oct 4, 2026 / Kyle Anzalone
Zelensky Says Ukraine Will Continue to Hit Russian Energy Infrastructure, Moscow Vows Response
Ukrainian President Volodymyr Zelensky said Russian forces were increasing the scope of their attacks, and he would respond by striking Russian energy infrastructure. Moscow threatened it would escalate attacks on Ukrainian military facilities, defense industry sites, and related infrastructure. Zelensky told Reuters in an interview on Saturday, “We saw documents, and we know that they […]
Read more
Apr 23, 2026 / Patrick Frise
God Bless Captain Vere: When Constitutional Duty Yields to Institutional Power
With President Trump demanding people in the armed forces as well as in other government offices do his bidding no matter what the law might be, it is time for people to learn the lesson of Captain Vere.
Read more
Jun 2, 2026 / Tyler Durden
Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to regulatory headwinds and raise the risk profile for approval.
Abivax's ABTECT maintenance data showed strong efficacy readout, with both once-daily obefazimod doses meeting the primary endpoint at week 44. Clinical remission rates were 50.8% for the 25 mg dose...
Read more




